Eli Lilly’s Antibody Med Shows Potential in Preventing COVID-19 in the Elderly | 2021-01-21
The Pharma Data
JANUARY 21, 2021
Eli Lilly reported yesterday that its monoclonal antibody bamlanivimab (LY-CoV555) significantly lessened the risk of contracting COVID-19 among nursing home residents and staff, according to findings from a phase 3 trial. James Miessler. Source link.
Let's personalize your content